$ Value
$0
Shares
226,665
Price
$0
Filed
Feb 6
Insider
Name
Tamayo Louis Edward
Title
Chief Financial Officer
CIK
0002083206
Roles
Transaction Details
Transaction Date
2026-02-04
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
226,665
Footnotes
The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2027, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date. | The reported securities are RSUs. | 25% of the shares underlying the option vest and become exercisable on February 4, 2027, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.
Filing Info
Tamayo Louis Edward's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-04 | LXEO | A | $0 |
| 2026-02-04 | LXEO | A | $0 |
| 2025-08-29 | LXEO | A | $0 |
| 2025-08-29 | LXEO | A | $0 |
Other Insiders at LXEO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Townsend Richard Nolan
Chief Executive Officer
|
— | $378K | 2026-04-06 |
|
Otero Jose Manuel
Chief Operating Officer
|
— | $26K | 2026-02-18 |
|
Tamayo Louis Edward
Chief Financial Officer
|
— | — | 2026-02-04 |
|
Bhalla Narinder Pal
Chief Medical Officer
|
— | — | 2026-02-13 |